Label: HEARTGARD- ivermectin tablet, chewable

  • NDC Code(s): 0010-4003-01, 0010-4004-01, 0010-4005-01
  • Packager: Boehringer Ingelheim Animal Health USA Inc.
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated December 12, 2023

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Chewables

    1051-2594-03

  • Caution

    Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

  • INDICATION

    For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for a month (30 days) after infection.

  • DOSAGE

    HEARTGARD® Chewables should be administered orally at monthly intervals at the recommended minimum dose level of 6.0 mcg of ivermectin per kilogram (2.72 mcg/lb) of body weight. (See ADMINISTRATION). The recommended dosage schedule for prevention of canine heartworm disease is as follows:

    Dog WeightChewables Per MonthIvermectin ContentColor Coding on Foil Backing and Carton
    Give dogs over 100 lb the appropriate combination of these chewables.
    HEARTGARD Chewables are recommended for use in dogs 6 weeks of age and older.

    Up to 25 lb

    1

    68 mcg

    Blue

    26 to 50 lb

    1

    136 mcg

    Green

    51 to 100 lb

    1

    272 mcg

    Brown

  • ADMINISTRATION

    Remove only one chewable at a time from the foil-backed blister card. Return the card with the remaining chewables to the box to protect the product from light. Because most dogs find HEARTGARD Chewables palatable, the product can be offered to the dog by hand. Alternatively, it may be added to a small amount of dog food. The chewable should be administered in a manner that encourages the dog to chew, rather than to swallow without chewing. Chewables may be broken into pieces and fed to dogs that normally swallow treats whole.

    Care should be taken to see that the dog consumes the complete dose, and treated animals should be observed for a few minutes after administration to ensure that part of the dose is not lost or rejected. If it is suspected that any of the dose has been lost, redosing is recommended.

    HEARTGARD Chewables should be given at monthly intervals during the period of the year when mosquitoes (vectors), potentially carrying infective heartworm larvae, are active. The initial dose must be given within a month (30 days) after the dog's first exposure to mosquitoes. The final dose must be given within a month (30 days) after the dog's last exposure to mosquitoes.

    When replacing another heartworm preventive in a heartworm disease preventive program, the first dose of HEARTGARD must be given within a month (30 days) after the last dose of the former medication.

    If the interval between doses exceeds a month (30 days), the efficacy of ivermectin can be reduced. For optimal performance, the chewable must be given once a month on or about the same day of the month. If treatment is delayed, whether by a few days or many, immediate treatment with HEARTGARD and resumption of the recommended dosing regimen minimizes the opportunity for the development of adult heartworms.

  • EFFICACY

    HEARTGARD® (ivermectin) Chewables, given orally using the recommended dose and regimen, are effective against the tissue larval stage of Dirofilaria immitis for a month (30 days) after infection and, as a result, prevent the development of the adult stage.

  • ACCEPTABILITY

    In acceptability and field trials, HEARTGARD Chewables were shown to be an acceptable oral dosage form that was consumed at the first offering by the majority of dogs.

  • PRECAUTIONS

    All dogs should be tested for existing heartworm infection before starting treatment with HEARTGARD which is not effective against adult D. immitis. Infected dogs must be treated to remove adult heartworms and microfilariae prior to initiating a program with HEARTGARD.

    While some microfilariae may be killed by the ivermectin in HEARTGARD at the recommended dose level, HEARTGARD is not effective for microfilariae clearance. A mild hypersensitivity-type reaction, presumably due to dead or dying microfilariae and particularly involving a transient diarrhea, has been observed in clinical trials with ivermectin after treatment of some dogs that have circulating microfilariae.

    Keep this and all drugs out of the reach of children. In case of ingestion by humans, clients should be advised to contact a physician immediately. Physicians may contact a Poison Control Center for advice concerning cases of ingestion by humans.

    Store between 68°F–77°F (20°–25°C). Excursions between 59°F-86°F (15°-30°C) are permitted. Protect product from light.

  • ADVERSE REACTIONS

    The following adverse reactions have been reported following the use of HEARTGARD: Depression/lethargy, vomiting, anorexia, diarrhea, mydriasis, ataxia, staggering, convulsions and hypersalivation.

    To report suspected adverse drug events, for technical assistance, or to obtain a copy of the Safety Data Sheet (SDS), contact Boehringer Ingelheim Animal Health USA Inc. at 1-888-637-4251. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS, or online at www.fda.gov/reportanimalae.

  • SAFETY

    HEARTGARD has shown a wide margin of safety at the recommended dose level in dogs (See PRECAUTIONS for exceptions) including pregnant or breeding bitches, stud dogs and puppies aged 6 or more weeks. In clinical trials, many commonly used flea collars, dips, shampoos, anthelmintics, antibiotics, vaccines, and steroid preparations have been administered with HEARTGARD Chewables in a heartworm disease preventive program.

    Studies with ivermectin indicate that certain dogs of the Collie breed are more sensitive to the effects of ivermectin administered at elevated dose levels (more than 16 times the target use level) than dogs of other breeds. At elevated doses, sensitive dogs showed adverse reactions which included mydriasis, depression, ataxia, tremors, drooling, paresis, recumbency, excitability, stupor, coma and death. HEARTGARD demonstrated no signs of toxicity at 10 times the recommended dose (60 mcg/kg) in sensitive Collies. Results of these trials support the safety of HEARTGARD products in dogs, including Collies, when used as recommended.

  • HOW SUPPLIED

    HEARTGARD Chewables are available in three dosage strengths (See DOSAGE section) for dogs of different weights. Each strength comes in convenient cartons of 6 chewables, packed 10 cartons per tray.

  • SPL UNCLASSIFIED SECTION

    Marketed by
    Boehringer Ingelheim Animal Health USA Inc.
    Duluth, GA 30096

    Approved by FDA under NADA # 140-886

    ©2019 Boehringer Ingelheim Animal Health USA Inc. All Rights Reserved.
    Made in the USA.
    December 2018

  • PRINCIPAL DISPLAY PANEL - 6 Tablet Carton (For DOGS UP TO 25 lbs)

    Heartgard®
    (ivermectin)

    Treat once a month to prevent
    heartworm disease in dogs.

    For
    DOGS
    UP TO 25 lbs

    6 Chewables
    Each chewable contains 68 mcg of ivermectin.

    Keep this and all drugs out
    of the reach of children.

    Caution: Federal (U.S.A.) law restricts
    this drug to use by or on the order of
    a licensed veterinarian.

    Boehringer Ingelheim

    Principal Display Panel - 6 Tablet Carton (For DOGS UP TO 25 lbs)
  • PRINCIPAL DISPLAY PANEL - 6 Tablet Carton (For DOGS 26-50 lbs)

    Heartgard®
    (ivermectin)

    Treat once a month to prevent
    heartworm disease in dogs.

    For
    DOGS
    26-50 lbs

    6 Chewables
    Each chewable contains 136 mcg of ivermectin.

    Keep this and all drugs out
    of the reach of children.

    Caution: Federal (U.S.A.) law restricts
    this drug to use by or on the order of
    a licensed veterinarian.

    Boehringer Ingelheim

    Principal Display Panel - 6 Tablet Carton (For DOGS 26-50 lbs)
  • PRINCIPAL DISPLAY PANEL - 6 Tablet Carton (For DOGS 51-100 lbs)

    Heartgard®
    (ivermectin)

    Treat once a month to prevent
    heartworm disease in dogs.

    For
    DOGS
    51-100 lbs

    6 Chewables
    Each chewable contains 272 mcg of ivermectin.

    Keep this and all drugs out
    of the reach of children.

    Caution: Federal (U.S.A.) law restricts
    this drug to use by or on the order of
    a licensed veterinarian.

    Boehringer Ingelheim

    Principal Display Panel - 6 Tablet Carton (For DOGS 51-100 lbs)
  • INGREDIENTS AND APPEARANCE
    HEARTGARD 
    ivermectin tablet, chewable
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:0010-4003
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ivermectin (UNII: 8883YP2R6D) (ivermectin - UNII:8883YP2R6D) ivermectin68 ug
    Product Characteristics
    ColorRED (red to red-brown) Scoreno score
    ShapeRECTANGLESize20mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0010-4003-011 in 1 CARTON
    16 in 1 BLISTER PACK
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA14088606/01/2020
    HEARTGARD 
    ivermectin tablet, chewable
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:0010-4004
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ivermectin (UNII: 8883YP2R6D) (ivermectin - UNII:8883YP2R6D) ivermectin136 ug
    Product Characteristics
    ColorRED (red to red-brown) Scoreno score
    ShapeRECTANGLESize27mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0010-4004-011 in 1 CARTON
    16 in 1 BLISTER PACK
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA14088606/01/2020
    HEARTGARD 
    ivermectin tablet, chewable
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:0010-4005
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ivermectin (UNII: 8883YP2R6D) (ivermectin - UNII:8883YP2R6D) ivermectin272 ug
    Product Characteristics
    ColorRED (red to red-brown) Scoreno score
    ShapeRECTANGLESize33mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0010-4005-011 in 1 CARTON
    16 in 1 BLISTER PACK
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA14088606/01/2020
    Labeler - Boehringer Ingelheim Animal Health USA Inc. (007134091)